Breaking News Instant updates and real-time market news.

NVAX

Novavax

$207.91 /

-1.69 (-0.81%)

16:07
06/14/21
06/14
16:07
06/14/21
16:07

Novavax reports 'positive' results from study of influenza/Covid vaccine

Novavax announced data from the first co-administration study of a SARS-CoV-2 vaccine candidate and an approved influenza vaccine. The findings suggest simultaneous vaccination may be a viable immunization strategy. In addition, the protection afforded by the candidate vaccine was consistent with the main study at 87.5% and 89.8% respectively. A preprint of the manuscript, 'Safety, Immunogenicity, and Efficacy of a COVID-19 Vaccine Co-administered With Seasonal Influenza Vaccines,' is available at medRxiv.org and has been submitted for peer-review. As part of Novavax' Phase 3 clinical trial of NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine candidate, in the United Kingdom, 431 volunteers were also enrolled in a co-administration sub-study, led by researchers at St George's, University of London and St George's Hospital, London. All received an approved seasonal influenza vaccine with approximately half the participants co-vaccinated with NVX-CoV2373 while the remainder received placebo. The study demonstrated that vaccine efficacy appeared to be preserved in those receiving both vaccines compared to those vaccinated with NVX-CoV2373 alone.

  • 17

    Jun

NVAX Novavax
$207.91 /

-1.69 (-0.81%)

06/07/21 B. Riley
Novavax risk/reward attractive into Covid vaccine data, says B. Riley
05/12/21
Fly Intel: Top five analyst downgrades
05/12/21 B. Riley
Novavax price target lowered to $286 from $365 at B. Riley
05/12/21 Cantor Fitzgerald
Novavax price target lowered to $217 from $338 at Cantor Fitzgerald

TODAY'S FREE FLY STORIES

Downgrade
Venator Materials downgraded to Neutral from Buy at BofA » 06:16
08/05/21
08/05
06:16
08/05/21
06:16
VNTR

Venator Materials

$3.15 /

-0.18 (-5.41%)

, TROX

Tronox

$17.81 /

-0.47 (-2.57%)

, CC

Chemours

$32.69 /

-1.45 (-4.25%)

BofA analyst Matthew …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TROX Tronox
$17.81 /

-0.47 (-2.57%)

CC Chemours
$32.69 /

-1.45 (-4.25%)

VNTR Venator Materials
$3.15 /

-0.18 (-5.41%)

06:02 Today BofA
Venator Materials downgraded to Neutral from Buy at BofA
08/04/21 Citi
Venator Materials price target lowered to $3.70 from $4.50 at Citi
02/25/21 Deutsche Bank
Venator Materials price target raised to $5.50 from $3 at Deutsche Bank
11/30/20 BofA
Venator Materials upgraded to Buy from Underperform at BofA
TROX Tronox
$17.81 /

-0.47 (-2.57%)

05/20/21
Fly Intel: Top five analyst initiations
05/20/21 BofA
BofA starts Tronox at Buy with $28 price target
05/20/21 BofA
Tronox initiated with a Buy at BofA
12/28/20 Alembic Global
Dow Inc., Olin, Tronox named among 2021 chemical top picks at Alembic Global
CC Chemours
$32.69 /

-1.45 (-4.25%)

08/03/21 RBC Capital
Chemours price target raised to $40 from $35 at RBC Capital
06/30/21 BMO Capital
Chemours price target raised to $48 from $42 at BMO Capital
06/09/21 Wolfe Research
Chemours initiated with an Outperform at Wolfe Research
06/09/21
Fly Intel: Top five analyst upgrades
VNTR Venator Materials
$3.15 /

-0.18 (-5.41%)

TROX Tronox
$17.81 /

-0.47 (-2.57%)

CC Chemours
$32.69 /

-1.45 (-4.25%)

  • 25
    Feb
TROX Tronox
$17.81 /

-0.47 (-2.57%)

CC Chemours
$32.69 /

-1.45 (-4.25%)

Recommendations
Mayville Engineering poised for growth in 2022, says Baird » 06:16
08/05/21
08/05
06:16
08/05/21
06:16
MEC

Mayville Engineering

$16.90 /

-0.63 (-3.59%)

Baird analyst Mircea…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MEC Mayville Engineering
$16.90 /

-0.63 (-3.59%)

MEC Mayville Engineering
$16.90 /

-0.63 (-3.59%)

06/25/21 Citi
Citi has 'increased conviction' in Mayville after management meetings
04/08/21 Baird
Mayville Engineering strategic customer adds to growth potential, says Baird
03/03/21 Baird
Mayville Engineering results suggest volume recovery continues, says Baird
02/04/21 Baird
Mayville Engineering price target raised to $20 from $14 at Baird
MEC Mayville Engineering
$16.90 /

-0.63 (-3.59%)

Earnings
ACI Worldwide reports Q2 EPS 6c, consensus 8c » 06:15
08/05/21
08/05
06:15
08/05/21
06:15
ACIW

ACI Worldwide

$32.54 /

-1.02 (-3.04%)

Reports Q2 revenue $302M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACIW ACI Worldwide
$32.54 /

-1.02 (-3.04%)

ACIW ACI Worldwide
$32.54 /

-1.02 (-3.04%)

05/06/21 BTIG
ACI Worldwide weakness due to lack of imminent sale signals, says BTIG
02/26/21 BTIG
ACI Worldwide sale 'still appears most likely outcome,' says BTIG
12/09/20 BTIG
ACI Worldwide price target raised to $46 from $39 at BTIG
12/08/20 Craig-Hallum
ACI Worldwide price target raised to $46 from $38 at Craig-Hallum
ACIW ACI Worldwide
$32.54 /

-1.02 (-3.04%)

ACIW ACI Worldwide
$32.54 /

-1.02 (-3.04%)

Earnings
Wesco raises FY21 adjusted EPS view to $8.40-$8.80 from $6.80-$7.30 » 06:14
08/05/21
08/05
06:14
08/05/21
06:14
WCC

Wesco

$105.89 /

-2.01 (-1.86%)

FY21 consensus $7.22.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WCC Wesco
$105.89 /

-2.01 (-1.86%)

WCC Wesco
$105.89 /

-2.01 (-1.86%)

08/03/21 Loop Capital
Wesco initiated with a Buy at Loop Capital
05/11/21 KeyBanc
Wesco price target raised to $125 from $96 at KeyBanc
05/10/21 Oppenheimer
Wesco price target raised to $125 from $90 at Oppenheimer
05/07/21 RBC Capital
Wesco price target raised to $119 from $109 at RBC Capital
WCC Wesco
$105.89 /

-2.01 (-1.86%)

WCC Wesco
$105.89 /

-2.01 (-1.86%)

Earnings
Walker & Dunlop reports Q2 EPS $1.73, consensus $2.04 » 06:14
08/05/21
08/05
06:14
08/05/21
06:14
WD

Walker & Dunlop

$102.76 /

+1.245 (+1.23%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WD Walker & Dunlop
$102.76 /

+1.245 (+1.23%)

WD Walker & Dunlop
$102.76 /

+1.245 (+1.23%)

06/14/21 Wolfe Research
Walker & Dunlop initiated with an Outperform at Wolfe Research
05/06/21 JMP Securities
Walker & Dunlop price target raised to $130 from $70 at JMP Securities
02/10/21 Wedbush
Walker & Dunlop price target raised to $112 from $98 at Wedbush
02/05/21 Keefe Bruyette
Walker & Dunlop price target raised to $90 from $85 at Keefe Bruyette
WD Walker & Dunlop
$102.76 /

+1.245 (+1.23%)

WD Walker & Dunlop
$102.76 /

+1.245 (+1.23%)

Recommendations
Ortho Clinical Diagnostics price target raised to $30 from $27 at H.C. Wainwright » 06:14
08/05/21
08/05
06:14
08/05/21
06:14
OCDX

Ortho Clinical Diagnostics

$21.81 /

+0.19 (+0.88%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OCDX Ortho Clinical Diagnostics
$21.81 /

+0.19 (+0.88%)

OCDX Ortho Clinical Diagnostics
$21.81 /

+0.19 (+0.88%)

08/04/21 Credit Suisse
Ortho Clinical Diagnostics assumed with an Outperform at Credit Suisse
07/13/21 Barclays
Ortho Clinical Diagnostics price target raised to $27 from $24 at Barclays
03/02/21 Barclays
Ortho Clinical Diagnostics initiated with an Overweight at Barclays
03/02/21 Barclays
Ortho Clinical Diagnostics initiated with an Overweight at Barclays
OCDX Ortho Clinical Diagnostics
$21.81 /

+0.19 (+0.88%)

  • 28
    Jan
OCDX Ortho Clinical Diagnostics
$21.81 /

+0.19 (+0.88%)

Recommendations
Dynavax price target raised to $20 from $16 at H.C. Wainwright » 06:13
08/05/21
08/05
06:13
08/05/21
06:13
DVAX

Dynavax

$9.88 /

+0.14 (+1.44%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DVAX Dynavax
$9.88 /

+0.14 (+1.44%)

DVAX Dynavax
$9.88 /

+0.14 (+1.44%)

02/08/21 Evercore ISI
Dynavax had 'big vaccine update week,' says Evercore ISI
02/01/21 Cowen
Dynavax undervalued for potential of Heplisav and COVID vaccine, says Cowen
02/01/21 H.C. Wainwright
Dynavax price target raised to $15 from $14 at H.C. Wainwright
11/06/20 H.C. Wainwright
Dynavax price target raised to $14 from $12 at H.C. Wainwright
DVAX Dynavax
$9.88 /

+0.14 (+1.44%)

DVAX Dynavax
$9.88 /

+0.14 (+1.44%)

DVAX Dynavax
$9.88 /

+0.14 (+1.44%)

Earnings
MultiPlan raises 2021 revenue view to $1.09B-$1.13B from $1.04B-$1.10B » 06:13
08/05/21
08/05
06:13
08/05/21
06:13
MPLN

MultiPlan

$7.72 /

-0.045 (-0.58%)

Consensus for FY21…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MPLN MultiPlan
$7.72 /

-0.045 (-0.58%)

MPLN MultiPlan
$7.72 /

-0.045 (-0.58%)

07/07/21 Citi
Citi sees policy change being narrowly applied, keeps Buy on MultiPlan
05/14/21 B. Riley
MultiPlan quarter highlights industry positioning, says B. Riley
04/07/21 B. Riley
B. Riley starts MultiPlan at Buy, sees 'meaningful investment opportunity'
04/06/21 B. Riley
MultiPlan initiated with a Buy at B. Riley
MPLN MultiPlan
$7.72 /

-0.045 (-0.58%)

MPLN MultiPlan
$7.72 /

-0.045 (-0.58%)

MPLN MultiPlan
$7.72 /

-0.045 (-0.58%)

Recommendations
Astec production improvements needed to improve sentiment, says Baird » 06:13
08/05/21
08/05
06:13
08/05/21
06:13
ASTE

Astec

$59.54 /

-1.46 (-2.39%)

Baird analyst Mircea…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASTE Astec
$59.54 /

-1.46 (-2.39%)

ASTE Astec
$59.54 /

-1.46 (-2.39%)

05/18/21 Baird
Astec capital deployment a potential catalyst, says Baird
05/06/21 Stifel
Astec upgraded to Buy at Stifel on 'encouraging' backlog and order trends
05/06/21 Stifel
Astec upgraded to Buy from Hold at Stifel
03/01/21 Baird
Astec price target raised to $92 from $90 at Baird
ASTE Astec
$59.54 /

-1.46 (-2.39%)

ASTE Astec
$59.54 /

-1.46 (-2.39%)

Recommendations
Clovis price target lowered to $10 from $12 at H.C. Wainwright » 06:13
08/05/21
08/05
06:13
08/05/21
06:13
CLVS

Clovis

$4.81 /

-0.04 (-0.82%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLVS Clovis
$4.81 /

-0.04 (-0.82%)

CLVS Clovis
$4.81 /

-0.04 (-0.82%)

06/07/21 Piper Sandler
Clovis reported 'underwhelming datasets' at ASCO, says Piper Sandler
03/19/21 Goldman Sachs
Goldman says Clovis reaction 'disproportionate' for already disclosed data
02/23/21 H.C. Wainwright
Clovis price target lowered to $13 from $15 at H.C. Wainwright
02/23/21 Piper Sandler
Clovis price target raised to $5.75 from $5.00 at Piper Sandler
CLVS Clovis
$4.81 /

-0.04 (-0.82%)

CLVS Clovis
$4.81 /

-0.04 (-0.82%)

CLVS Clovis
$4.81 /

-0.04 (-0.82%)

Earnings
Wesco reports Q2 adjusted EPS $2.64, consensus $1.90 » 06:12
08/05/21
08/05
06:12
08/05/21
06:12
WCC

Wesco

$105.89 /

-2.01 (-1.86%)

Reports Q2 revenue $4.6B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WCC Wesco
$105.89 /

-2.01 (-1.86%)

WCC Wesco
$105.89 /

-2.01 (-1.86%)

08/03/21 Loop Capital
Wesco initiated with a Buy at Loop Capital
05/11/21 KeyBanc
Wesco price target raised to $125 from $96 at KeyBanc
05/10/21 Oppenheimer
Wesco price target raised to $125 from $90 at Oppenheimer
05/07/21 RBC Capital
Wesco price target raised to $119 from $109 at RBC Capital
WCC Wesco
$105.89 /

-2.01 (-1.86%)

WCC Wesco
$105.89 /

-2.01 (-1.86%)

Periodicals
Spirit sees number of canceled flights starting to fall Thursday, WSJ reports » 06:12
08/05/21
08/05
06:12
08/05/21
06:12
SAVE

Spirit Airlines

$25.75 /

-1.025 (-3.83%)

Spirit Airlines canceled…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SAVE Spirit Airlines
$25.75 /

-1.025 (-3.83%)

SAVE Spirit Airlines
$25.75 /

-1.025 (-3.83%)

06/15/21
Fly Intel: Top five analyst upgrades
06/15/21 Citi
Spirit Airlines upgraded to Buy from Neutral at Citi
06/09/21 MKM Partners
MKM sees 'a lot to like' in Spirit Airlines' valuation
06/09/21 MKM Partners
Spirit Airlines initiated with a Buy at MKM Partners
SAVE Spirit Airlines
$25.75 /

-1.025 (-3.83%)

SAVE Spirit Airlines
$25.75 /

-1.025 (-3.83%)

SAVE Spirit Airlines
$25.75 /

-1.025 (-3.83%)

SAVE Spirit Airlines
$25.75 /

-1.025 (-3.83%)

Recommendations
HubSpot price target raised to $675 from $615 at Piper Sandler » 06:12
08/05/21
08/05
06:12
08/05/21
06:12
HUBS

HubSpot

$588.93 /

+4.21 (+0.72%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HUBS HubSpot
$588.93 /

+4.21 (+0.72%)

HUBS HubSpot
$588.93 /

+4.21 (+0.72%)

07/21/21 Stifel
HubSpot price target raised to $600 from $565 at Stifel
05/06/21 Jefferies
HubSpot price target raised to $600 from $525 at Jefferies
05/06/21 BMO Capital
HubSpot price target raised to $585 from $565 at BMO Capital
05/06/21 Canaccord
HubSpot price target raised to $580 from $560 at Canaccord
HUBS HubSpot
$588.93 /

+4.21 (+0.72%)

HUBS HubSpot
$588.93 /

+4.21 (+0.72%)

Earnings
MultiPlan reports Q2 EPS (7c), consensus 2c » 06:11
08/05/21
08/05
06:11
08/05/21
06:11
MPLN

MultiPlan

$7.72 /

-0.045 (-0.58%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MPLN MultiPlan
$7.72 /

-0.045 (-0.58%)

MPLN MultiPlan
$7.72 /

-0.045 (-0.58%)

07/07/21 Citi
Citi sees policy change being narrowly applied, keeps Buy on MultiPlan
05/14/21 B. Riley
MultiPlan quarter highlights industry positioning, says B. Riley
04/07/21 B. Riley
B. Riley starts MultiPlan at Buy, sees 'meaningful investment opportunity'
04/06/21 B. Riley
MultiPlan initiated with a Buy at B. Riley
MPLN MultiPlan
$7.72 /

-0.045 (-0.58%)

MPLN MultiPlan
$7.72 /

-0.045 (-0.58%)

MPLN MultiPlan
$7.72 /

-0.045 (-0.58%)

Initiation
PointsBet initiated with a Positive at Susquehanna » 06:11
08/05/21
08/05
06:11
08/05/21
06:11
PBTHF

PointsBet

/

+

Susquehanna analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PBTHF PointsBet
/

+

PBTHF PointsBet
/

+

03/30/21 Goldman Sachs
PointsBet initiated with a Buy at Goldman Sachs
10/28/20 JPMorgan
PointsBet upgraded to Neutral from Underweight at JPMorgan
Downgrade
GoDaddy downgraded to Neutral from Overweight at Piper Sandler » 06:11
08/05/21
08/05
06:11
08/05/21
06:11
GDDY

GoDaddy

$83.47 /

-0.55 (-0.65%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GDDY GoDaddy
$83.47 /

-0.55 (-0.65%)

GDDY GoDaddy
$83.47 /

-0.55 (-0.65%)

07/19/21 Morgan Stanley
GoDaddy initiated with an Equal Weight at Morgan Stanley
07/13/21 Truist
GoDaddy expanded integration with Google a positive, says Truist
06/28/21 Barclays
GoDaddy price target raised to $115 from $107 at Barclays
04/08/21 Citi
GoDaddy acquisition of domains a positive, says Citi
GDDY GoDaddy
$83.47 /

-0.55 (-0.65%)

GDDY GoDaddy
$83.47 /

-0.55 (-0.65%)

Earnings
Cigna backs FY21 adjusted EPS view at least $20.20, consensus $20.42 » 06:11
08/05/21
08/05
06:11
08/05/21
06:11
CI

Cigna

$231.32 /

-2.72 (-1.16%)

Raises FY21 revenue view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CI Cigna
$231.32 /

-2.72 (-1.16%)

CI Cigna
$231.32 /

-2.72 (-1.16%)

07/02/21 Mizuho
CVS Health came out on top in PBM checks, says Mizuho
05/18/21 Wells Fargo
Cigna initiated with an Equal Weight at Wells Fargo
05/14/21 RBC Capital
Cigna price target raised to $304 from $265 at RBC Capital
05/10/21 Credit Suisse
Cigna price target raised to $300 from $270 at Credit Suisse
CI Cigna
$231.32 /

-2.72 (-1.16%)

CI Cigna
$231.32 /

-2.72 (-1.16%)

CI Cigna
$231.32 /

-2.72 (-1.16%)

Recommendations
Nevro price target lowered to $160 from $190 at JMP Securities » 06:10
08/05/21
08/05
06:10
08/05/21
06:10
NVRO

Nevro

$147.83 /

-3.47 (-2.29%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVRO Nevro
$147.83 /

-3.47 (-2.29%)

NVRO Nevro
$147.83 /

-3.47 (-2.29%)

06:06 Today Piper Sandler
Nevro downgraded to Neutral from Overweight at Piper Sandler
06:00 Today Citi
Nevro downgraded to Neutral from Buy at Citi
05:57 Today Citi
Nevro downgraded to Neutral from Buy at Citi
04:46 Today Wells Fargo
Nevro downgraded to Equal Weight from Overweight at Wells Fargo
NVRO Nevro
$147.83 /

-3.47 (-2.29%)

NVRO Nevro
$147.83 /

-3.47 (-2.29%)

Initiation
Flutter Entertainment initiated with a Positive at Susquehanna » 06:10
08/05/21
08/05
06:10
08/05/21
06:10
PDYPY

Flutter Entertainment

$85.01 /

+1.21 (+1.44%)

Susquehanna analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PDYPY Flutter Entertainment
$85.01 /

+1.21 (+1.44%)

PDYPY Flutter Entertainment
$85.01 /

+1.21 (+1.44%)

07/28/21 Citi
Flutter Entertainment price target raised to 11,700 GBp at Citi
07/28/21 Peel Hunt
Flutter Entertainment upgraded to Buy from Reduce at Peel Hunt
07/27/21 JPMorgan
Flutter Entertainment upgraded to Overweight from Neutral at JPMorgan
07/22/21 RBC Capital
Flutter Entertainment upgraded to Outperform from Sector Perform at RBC Capital
PDYPY Flutter Entertainment
$85.01 /

+1.21 (+1.44%)

PDYPY Flutter Entertainment
$85.01 /

+1.21 (+1.44%)

Hot Stocks
Bayer to acquire Vividion Therapeutics for up to $2B » 06:09
08/05/21
08/05
06:09
08/05/21
06:09
BAYRY

Bayer

$14.80 /

-0.15 (-1.00%)

Bayer announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BAYRY Bayer
$14.80 /

-0.15 (-1.00%)

BAYRY Bayer
$14.80 /

-0.15 (-1.00%)

08/04/21 AlphaValue
Bayer downgraded to Add from Buy at AlphaValue
05/19/21 Morgan Stanley
Bayer price target raised to EUR 71 from EUR 70 at Morgan Stanley
05/19/21 JPMorgan
JPMorgan upgrades Bayer to Overweight with earnings at 'turning point'
05/18/21 JPMorgan
Bayer upgraded to Overweight from Neutral at JPMorgan
BAYRY Bayer
$14.80 /

-0.15 (-1.00%)

BAYRY Bayer
$14.80 /

-0.15 (-1.00%)

BAYRY Bayer
$14.80 /

-0.15 (-1.00%)

Hot Stocks
Murphy Oil tightens FY21 production view to 157.5-165.5 MBOEPD » 06:09
08/05/21
08/05
06:09
08/05/21
06:09
MUR

Murphy Oil

$20.04 /

-1.21 (-5.69%)

Had seen 155-165 MBOEPD.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MUR Murphy Oil
$20.04 /

-1.21 (-5.69%)

MUR Murphy Oil
$20.04 /

-1.21 (-5.69%)

07/15/21 Mizuho
Murphy Oil price target raised to $28 from $24 at Mizuho
07/01/21 Truist
Murphy Oil price target raised to $36 from $24 at Truist
05/17/21 Mizuho
Murphy Oil price target raised to $24 from $21 at Mizuho
04/20/21 Mizuho
Murphy Oil price target lowered to $21 from $22 at Mizuho
MUR Murphy Oil
$20.04 /

-1.21 (-5.69%)

MUR Murphy Oil
$20.04 /

-1.21 (-5.69%)

Recommendations
Fastly price target lowered to $32 from $45 at Piper Sandler » 06:09
08/05/21
08/05
06:09
08/05/21
06:09
FSLY

Fastly

$44.50 /

-1.7 (-3.68%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FSLY Fastly
$44.50 /

-1.7 (-3.68%)

FSLY Fastly
$44.50 /

-1.7 (-3.68%)

04:40 Today William Blair
Fastly downgraded to Market Perform from Outperform at William Blair
06/10/21 RBC Capital
Fastly initiated with a Sector Perform at RBC Capital
06/10/21
Fly Intel: Top five analyst downgrades
06/10/21 Oppenheimer
Oppenheimer downgrades Fastly on increased risk following shutdown
FSLY Fastly
$44.50 /

-1.7 (-3.68%)

FSLY Fastly
$44.50 /

-1.7 (-3.68%)

FSLY Fastly
$44.50 /

-1.7 (-3.68%)

FSLY Fastly
$44.50 /

-1.7 (-3.68%)

Earnings
Yeti raises FY21 adjusted EPS view to $2.42-$2.46 from $2.28-$2.32 » 06:09
08/05/21
08/05
06:09
08/05/21
06:09
YETI

Yeti

$99.80 /

-0.15 (-0.15%)

FY21 consensus $2.35.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
YETI Yeti
$99.80 /

-0.15 (-0.15%)

YETI Yeti
$99.80 /

-0.15 (-0.15%)

08/03/21 Piper Sandler
Yeti price target raised to $112 from $104 at Piper Sandler
08/02/21 Baird
Yeti price target raised to $110 from $100 at Baird
07/14/21 Goldman Sachs
Yeti initiated with a Buy at Goldman Sachs
06/23/21 UBS
Yeti initiated with a Neutral at UBS
YETI Yeti
$99.80 /

-0.15 (-0.15%)

YETI Yeti
$99.80 /

-0.15 (-0.15%)

YETI Yeti
$99.80 /

-0.15 (-0.15%)

YETI Yeti
$99.80 /

-0.15 (-0.15%)

Hot Stocks
Murphy Oil sees Q3 production 162-170 MBOEPD  06:08
08/05/21
08/05
06:08
08/05/21
06:08
MUR

Murphy Oil

$20.04 /

-1.21 (-5.69%)

 
ShowHide Related Items >><<
MUR Murphy Oil
$20.04 /

-1.21 (-5.69%)

MUR Murphy Oil
$20.04 /

-1.21 (-5.69%)

07/15/21 Mizuho
Murphy Oil price target raised to $28 from $24 at Mizuho
07/01/21 Truist
Murphy Oil price target raised to $36 from $24 at Truist
05/17/21 Mizuho
Murphy Oil price target raised to $24 from $21 at Mizuho
04/20/21 Mizuho
Murphy Oil price target lowered to $21 from $22 at Mizuho
MUR Murphy Oil
$20.04 /

-1.21 (-5.69%)

MUR Murphy Oil
$20.04 /

-1.21 (-5.69%)

Earnings
Cigna reports Q2 adjusted EPS $5.24, consensus $4.96 » 06:08
08/05/21
08/05
06:08
08/05/21
06:08
CI

Cigna

$231.32 /

-2.72 (-1.16%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CI Cigna
$231.32 /

-2.72 (-1.16%)

CI Cigna
$231.32 /

-2.72 (-1.16%)

07/02/21 Mizuho
CVS Health came out on top in PBM checks, says Mizuho
05/18/21 Wells Fargo
Cigna initiated with an Equal Weight at Wells Fargo
05/14/21 RBC Capital
Cigna price target raised to $304 from $265 at RBC Capital
05/10/21 Credit Suisse
Cigna price target raised to $300 from $270 at Credit Suisse
CI Cigna
$231.32 /

-2.72 (-1.16%)

CI Cigna
$231.32 /

-2.72 (-1.16%)

CI Cigna
$231.32 /

-2.72 (-1.16%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.